ResearchAarkstoreEnterprise Disease and Therapy Review: Alzheimers Disease
http://www.aarkstore.com/publishers/pubreports.asp? PubId=38&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Disease&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Therapy%20&PubId=&pagenum=1 http://www.aarkstore.com/search/viewresults.asp? search=Review&PubId=&pagenum=1 The Alzheimer Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the Alzheimer's and dementia market, as well as sales of leading drugs and therapies are provided. Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Table of Contents :
I. OVERVIEW General overview of the condition Risk factors Symptoms
II. INCIDENCE AND PREVALENCE Incidence Table (US, UK, Eastern Europe, Northern Europe, Southern Europe, Western Europe) Prevalence Table (US, Canada, UK, France, Italy, Spain, Japan, China, India, Eastern Europe, Northern Europe, Southern Europe, Western Europe, Worldwide)
III. DIAGNOSIS Tools and tests used to diagnose Alzheimer disease
IV. TREAMENT Treating cognitive symptoms Treating behavioral and psychiatric symptoms
V. DOSING Dosing for FDA approved treatments
VI. TREATMENT COSTS Costs for commonly prescribed non-generic drugs
VII. MARKET SIZE Market overview Sales information for key pharmaceuticals
VIII. COMMENTS IX. REFERENCES/RESOURCES For more information please visit link: http://www.aarkstore.com/reports/Disease-and-Therapy-Review-Alzheimer-Disease171660.html Neel Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://www.facebook.com/aarkstoreenterprise
Disease and Therapy Review: ESRD Disease and Therapy Review: Alzheimer Disease Disease and Therapy Review: Migraine Disease and Therapy Review: Stroke Disease and Therapy Review: Rheumatoid Arthritis Disease and Therapy Review: Obesity Disease and Therapy Review:Major Depressive Disorder Disease and Therapy Review: HIV/AIDS Disease and Therapy Review: Epilepsy Disease and Therapy Review: Parkinson's Disease
Disease and Therapy Review: Heart Failure Disease and Therapy Review: Hepatitis C Disease and Therapy Review: Bipolar Disorder Disease and Therapy Review: Breast Cancer Asthma – Executive Market Summary 2011 Bladder Cancer – Executive Market Summary 2011 Colorectal Cancer – Executive Market Summary 2011 Chronic Obstructive Pulmonary Disease (COPD) – Executive Market Summary 2011 Onychomycosis – Executive Market Summary 2011 Ulcerative Colitis – Executive Market Summary 2011 Impetigo – Executive Market Summary 2011